Rutgers, The State University Of New Jersey
Clinical trials sponsored by Rutgers, The State University Of New Jersey, explained in plain language.
-
Experimental Virus-Antibody combo tested for tough skin cancers
Disease control TerminatedThis early-phase study tested a combination of two drugs—a virus-based therapy (talimogene laherparepvec) and an antibody (panitumumab)—in 5 people with advanced skin squamous cell carcinoma that had spread or come back. The goal was to see if the combination was safe and could s…
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New combo therapy for tough lung cancer shows early promise in safety study
Disease control TerminatedThis early-phase trial tested a combination of two immunotherapy drugs (atezolizumab and varlilumab) plus radiation in 16 people with advanced non-small cell lung cancer that had stopped responding to prior treatment. The main goal was to check safety and side effects. The study …
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 20, 2026 11:57 UTC